Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-01-29, Stock:JNJ, The news for the past five days is as follows:
2018-01-22: NEWS1: These 3 Dow Stocks, This Hot Chipmaker, United Airlines Earnings On Tap: Investing Action Plan.NEWS2: These 3 Dow Stocks, This Hot Chipmaker, United Airlines Earnings On Tap: Investing Action Plan.NEWS3: [$$] Johnson & Johnson's Earnings Are Coming. Here's What to Watch..NEWS4: 3 Stocks Likely to Beat Earnings Estimates This Week.NEWS5: Dow Analyst Moves: JNJ.NEWS6: Healthcare ETFs to Watch As Q4 Earnings Unfold.NEWS7: 3 Stocks Likely to Beat Earnings Estimates This Week.NEWS8: Earnings Preview: Johnson & Johnson And Procter & Gamble Take The Stage Tomorrow Morning.NEWS9: Wynn Resorts, Imax, Johnson & Johnson, Ford and Starbucks as Zacks Bull and Bear of the Day.NEWS10: Analyst Ratings and Recommendations for Johnson & Johnson.NEWS11: Wynn Resorts, Imax, Johnson & Johnson, Ford and Starbucks as Zacks Bull and Bear of the Day.NEWS12: These 2 Developments Could Accelerate Johnson & Johnson's Next Acquisition.NEWS13: What JNJ’s Stock Valuation Tells Us.NEWS14: Johnson & Johnson’s Medical Devices Segment: 4Q17 Estimates.NEWS15: Merck & Co.’s Animal Health Business in 3Q17.NEWS16: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS17: Johnson & Johnson Is Trading at an All-Time High—What’s Next?.NEWS18: Johnson & Johnson’s Consumer Segment: 4Q17 Estimates.NEWS19: What Analysts Recommend for Bristol-Myers Squibb in January 2018.NEWS20: These 2 Developments Could Accelerate Johnson & Johnson&apos;s Next Acquisition.NEWS21: Sanofi to buy U.S. haemophilia group Bioverativ for $11.6 bln.
2018-01-23: NEWS1: With stocks like FB or P&G, check your bias at the door.NEWS2: Cramer: Check your bias at the door with stocks like Face....NEWS3: Nasdaq Up, Bitcoin Fund Down; Will These 4 Big Cap Techs Beat Apple In 2018?.NEWS4: Stocks End Mixed With Earnings in Focus.NEWS5: Asian Markets Mostly Lower.NEWS6: Nasdaq Leads Stocks Higher As Netflix Sparks Leisure Sector.NEWS7: Johnson & Johnson Stock Dips Despite Q4 Earnings Beat.NEWS8: Close Update: Nasdaq Rally Powered by FANG Stocks.NEWS9: [$$] Johnson & Johnson Results Driven by Pharmaceutical Sales Growth.NEWS10: Market Close Report: Historical high reached as NASDAQ Composite Index closes at 7,460.29..NEWS11: Dow Closes Wild Tuesday on Sour Note.NEWS12: Netflix and Whirlpool jump while Twitter and J&J fall.NEWS13: Thai Shares May Inch Higher Again On Wednesday.NEWS14: Thai Shares May Inch Higher Again On Wednesday.NEWS15: Health Care Sector Update for 01/23/2018: VYGR,ALT,JNJ,OBLN.NEWS16: Japanese Market Declines.NEWS17: Japanese Market Declines.NEWS18: Johnson & Johnson loses $10.7B after sweeping US tax changes.NEWS19: Where's The Tylenol? J&J Disappoints And Frustrates.NEWS20: Netflix lifts S&P, Nasdaq; J&J, Procter hold Dow in check.NEWS21: Markets Right Now: Tech stocks send indexes mostly higher.NEWS22: Indonesia Bourse Overdue For Consolidation.NEWS23: Indonesia Bourse Overdue For Consolidation.NEWS24: Australian Market Modestly Higher.NEWS25: Australian Market Modestly Higher.NEWS26: Hong Kong Market May Test Resistance At 33,000.NEWS27: Hong Kong Market May Test Resistance At 33,000.NEWS28: Nasdaq Solidly Higher As FANGs Bare Their Teeth Again.NEWS29: China Bourse Called Higher Again On Wednesday.NEWS30: China Bourse Called Higher Again On Wednesday.NEWS31: U.S. appeals court upholds ruling invalidating J&J patent on Remicade.NEWS32: J&J takes $13.6 billion charge related to new U.S. tax law.NEWS33: Win Streak May Continue For Taiwan Stock Market.NEWS34: Win Streak May Continue For Taiwan Stock Market.NEWS35: Health Care Sector Update for 01/23/2018: OBLN,ALT,JNJ.NEWS36: Should J&J Spin Off Its Consumer Business?.NEWS37: Singapore Stock Market May Flirt With 3,600-Point Level.NEWS38: Singapore Stock Market May Flirt With 3,600-Point Level.NEWS39: The new tax law won't change Johnson & Johnson's M&A strategy, CEO says.NEWS40: Johnson & Johnson's guidance impresses before 'disappointing'.NEWS41: Malaysia Shares Draw Flat Lead For Wednesday.NEWS42: Malaysia Shares Draw Flat Lead For Wednesday.NEWS43: Mid-Day Update: Netflix Powers Nasdaq to New Heights.NEWS44: Johnson & Johnson Earnings: When Strong Isn't Strong Enough.NEWS45: Johnson & Johnson takes $13.6 billion charge related to new U.S. tax law.NEWS46: JNJ, PG, TRV, KMB Post Q4 Earnings.NEWS47: J&J takes $13.6 bln charge related to new U.S. tax law.NEWS48: The US is in a baby bust, so diaper makers need a new plan.NEWS49: South Korea Bourse May Add To Its Winnings.NEWS50: South Korea Bourse May Add To Its Winnings.NEWS51: Can Intuitive Surgical Beat Analyst Estimates Again in 4Q17?.NEWS52: Johnson & Johnson Shares Fall Despite Earnings Beat.NEWS53: Don't Expect a Huge J&J Investment Surge.NEWS54: Johnson & Johnson Stock Dips Despite Q4 Earnings Beat.NEWS55: Stocks Trim Early Gains; Netflix Surges On New Subscriber Growth.NEWS56: Dow Movers: PG, TRV.NEWS57: Big Morning for Q4 Earnings: JNJ, PG, TRV, KMB and More.NEWS58: Johnson & Johnson loses $10.7B after sweeping US tax changes.NEWS59: U.S. appeals court upholds ruling invalidating J&J patent on Remicade.NEWS60: Nasdaq, S&P 500 Reach New Record Closing Highs - U.S. Commentary.NEWS61: Nasdaq, S&P 500 Reach New Record Closing Highs - U.S. Commentary.NEWS62: JNJ, PG, TRV, KMB Post Q4 Earnings.NEWS63: J&J takes $13.6 billion charge related to new U.S. tax law.NEWS64: U.S. appeals court invalidates J&J patent on Remicade.NEWS65: Drug companies told to do more to tackle 'superbug' crisis.NEWS66: Big Morning for Q4 Earnings: JNJ, PG, TRV, KMB and More.NEWS67: Dow&apos;s J&J Tops Quarterly Views; Earnings Outlook Helped By Tax Cut.NEWS68: Stocks Trade Mixed, Nasdaq Hits Record as Netflix Soars.NEWS69: 3 Stocks That Feel Like Disney in 1957.NEWS70: Johnson & Johnson Loses Remicade Patent in Appeal Ruling.NEWS71: The Top 5 Johnson & Johnson Shareholders (JNJ).NEWS72: Stocks to Watch: Netflix, J&J, Travelers, Tesla, JPMorgan, Twitter, Apple, P&G, Verizon.NEWS73: Tax Losses Mask Johnson & Johnson&apos;s Fundamental Strength.NEWS74: J&J (JNJ) Q4 Earnings Top, Pharma Sales Continue to Improve.NEWS75: Calculating The Intrinsic Value Of Johnson & Johnson (NYSE:JNJ).NEWS76: Johnson & Johnson Takes on $14 Billion Tax Charge With Q4 Earnings.NEWS77: J&J CFO Says Tax Benefits to Spark Innovation Investment.NEWS78: J&J (JNJ) Beats on Q4 Earnings, Misses Sales, Shares Up.NEWS79: Stocks making the biggest moves premarket: JNJ, PG, VZ, JPM, NFLX, ADBE & more.NEWS80: Stocks Mostly Positive In Mid-Day Trading - U.S. Commentary.NEWS81: Stocks Mostly Positive In Mid-Day Trading - U.S. Commentary.NEWS82: Johnson & Johnson's stock rallies after profit beat expectations, provides upbeat outlook.NEWS83: Johnson & Johnson Reports 2017 Fourth-Quarter Results:.NEWS84: China's Sinocare in deal talks, it says after reported interest in J&J unit.NEWS85: Cancer drugs, Actelion deal boost Johnson & Johnson's revenue, earnings.NEWS86: Canadian Stocks Are Down On NAFTA Concerns - Canadian Commentary.NEWS87: Canadian Stocks Are Down On NAFTA Concerns - Canadian Commentary.NEWS88: Johnson & Johnson Q4 17 Earnings Conference Call At 8:30 AM ET.NEWS89: Johnson & Johnson Q4 17 Earnings Conference Call At 8:30 AM ET.NEWS90: Johnson & Johnson Q4 Results Top Estimates; Sees FY18 Profit Above View.NEWS91: Johnson & Johnson Q4 Results Top Estimates; Sees FY18 Profit Above View.NEWS92: Futures Suggest Lower Opening For Wall Street.NEWS93: Johnson & Johnson Q4 Earnings Rise 10%.NEWS94: Earnings In Focus: Jan. 23 (FUL, ATI, JNJ, PG, VZ).NEWS95: 3 Stocks You Can Safely Own Until 2030.
2018-01-24: NEWS1: NYC Joins Cities, Counties and States In Bringing Opioid Lawsuit.NEWS2: Johnson & Johnson Stock Is In The Perfect Buy Zone.NEWS3: How Juno Therapeutics’ Cellular Immunotherapy Portfolio Could Help Celgene.NEWS4: Healthcare ETFs in Focus Post JNJ Q4 Results.NEWS5: Stock Market News For Jan 24, 2018.NEWS6: Here’s Why Toilet Paper, Razors, and Baby Diapers Are About to Get Cheaper.NEWS7: Stock Market News For Jan 24, 2018.NEWS8: Johnson & Johnson Dips Despite Posting a Strong Q4.NEWS9: Johnson & Johnson Stock Is In The Perfect Buy Zone.NEWS10: Healthcare ETFs in Focus Post JNJ Q4 Results.NEWS11: Why Amgen is a Top Socially Responsible Dividend Stock (AMGN).NEWS12: Health Care Sector Update for 01/24/2018: JNJ, PFE, ABT, MRK, AMGN, STML, AERI, BSX.NEWS13: Today’s Research Reports on Stocks to Watch: Johnson & Johnson and Procter & Gamble.NEWS14: Here's How to Find the Best Dividend Stocks.NEWS15: Weakness in the Dollar Could Spell Trouble for Stocks.NEWS16: Here&apos;s How to Find the Best Dividend Stocks.NEWS17: [$$] Johnson & Johnson Results Driven by Pharmaceutical Sales Growth.NEWS18: Stocks Flatline as VIX Remains Buoyant.
2018-01-25: NEWS1: Will Pfizer (PFE) Surpass Estimates This Earnings Season?.NEWS2: Markets Right Now: Stocks end a choppy day of trading mixed.NEWS3: Boeing, 3M Dominate DJIA on Thursday.NEWS4: Will Pfizer (PFE) Surpass Estimates This Earnings Season?.NEWS5: Pfizer's Rituxan Biosimilar Meets Endpoint in Phase III.NEWS6: SPTM, JPM, JNJ, MA: ETF Inflow Alert.NEWS7: Pfizer in 4Q17: Revenue Estimates Based on Geographies.NEWS8: Pfizer: Revenue Growth Is Expected in 4Q17.NEWS9: Pfizer&apos;s Rituxan Biosimilar Meets Endpoint in Phase III.NEWS10: Exclusive: J&J out of race for Pfizer's $20 billion consumer unit as deadline looms.NEWS11: Free Research Report as Johnson & Johnson’s Adjusted Earnings Rose to Outshine Forecasts.NEWS12: Celgene on the Street: Analysts Recommendations in January.NEWS13: Four Things to Know About the Q4 Earnings Season.NEWS14: Johnson & Johnson Down Small on Huge Loss -- What Gives?.NEWS15: Johnson & Johnson Down Small on Huge Loss -- What Gives?.NEWS16: Tax Reform Benefits More About Paying Down Debt Than M&A: BofA Merrill Lynch.
2018-01-26: NEWS1: Pfizer Inc. Stock Rises From the Dead, Deserves to Be in Your Portfolio.NEWS2: Pfizer Inc. Stock Rises From the Dead, Deserves to Be in Your Portfolio.NEWS3: AbbVie (ABBV) Q4 Earnings Beat, 2018 View Raised, Shares Up.NEWS4: AbbVie (ABBV) Q4 Earnings Beat, 2018 View Raised, Shares Up.NEWS5: AbbVie (ABBV) Q4 Earnings Beat, 2018 View Raised, Shares Up.NEWS6: Health care costs are still a crushing problem.NEWS7: Zacks Earnings Trends Highlights: Citigroup, Johnson & Johnson, IBM and General Electric.NEWS8: Will J&J (JNJ) Witness Deceleration in 2018 Sales Growth?.NEWS9: These Drug Companies Are Best Positioned to Fight a ‘Superbug’.NEWS10: Will J&J (JNJ) Witness Deceleration in 2018 Sales Growth?.NEWS11: Zacks Earnings Trends Highlights: Citigroup, Johnson & Johnson, IBM and General Electric.NEWS12: Pfizer’s 4Q17 Estimates: Products with Lower Sales.NEWS13: What to Expect for Novartis’s Subsidiary Alcon in 2018.NEWS14: New York City Sues Big Pharma For Opioid Epidemic, But Does The Lawsuit Make Sense?.NEWS15: What Are Pfizer’s Positive Growth Contributors?.

Answer: Decrease